Citation Impact
Citing Papers
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
2005 Standout
Defining the clinical course of multiple sclerosis
1996 Standout
Topographic Comparative Study of Magnetic Resonance Imaging and Electroencephalography in 34 Children with Tuberous Sclerosis
1990
Diffuse Axonal and Tissue Injury in Patients With Multiple Sclerosis With Low Cerebral Lesion Load and No Disability
2002
Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis
1996
Optical coherence tomography angiography
2017 Standout
The Corticosteroid Receptor Hypothesis of Depression
2000 Standout
Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis
1996
Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis
2008 Standout
Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis
2005 Standout
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis
1997
The spectrum of neuromyelitis optica
2007 Standout
Natural history of multiple sclerosis: a unifying concept
2006
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
2010 Standout
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
2001 Standout
Spinal-cord injury
2002 Standout
Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible
1997
Imaging of multiple sclerosis: Role in neurotherapeutics
2005
The Clinical Epidemiology of Multiple Sclerosis
2008
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
2003
Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions
1994
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
2002 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Multiple sclerosis
2008 Standout
Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis
1998
Salivary cortisol as a biomarker in stress research
2008 Standout
Glucocorticoids Suppress Corticotropin-Releasing Hormone and Vasopressin Expression in Human Hypothalamic Neurons1
1998
The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up
1998
Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases.
1994
Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
2000 Standout
Immunopathology of multiple sclerosis
2015 Standout
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Mechanisms of axonal dysfunction after spinal cord injury: with an emphasis on the role of voltage-gated potassium channels
2001
N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology
2007 Standout
Demyelination: The Role of Reactive Oxygen and Nitrogen Species
1999
Tuberous sclerosis
2008 Standout
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
2006 Standout
The role of oxidative stress in the pathogenesis of multiple sclerosis: The need for effective antioxidant therapy
2004 Standout
Neuropsychiatric Aspects of Tuberous Sclerosis
1991
Axonal Transection in the Lesions of Multiple Sclerosis
1998 Standout
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
2011 Standout
The blood–brain barrier
2016
Metabolism and functions of glutathione in brain
2000 Standout
Age at disability milestones in multiple sclerosis
2006
The role of nitric oxide in multiple sclerosis
2002
Recovery from optic neuritis is associated with a change in the distribution of cerebral response to visual stimulation: a functional magnetic resonance imaging study
2000
Multiple Sclerosis
2000 Standout
Nitric oxide, mitochondria and neurological disease
1999
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration
2010
An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis
2011 Standout
Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia
2003 Standout
The role of magnetic resonance techniques in understanding and managing multiple sclerosis
1998
Spatial mapping of T2 and gadolinium-enhancing T1 lesion volumes in multiple sclerosis: evidence for distinct mechanisms of lesion genesis?
1999
The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system
1996
New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes
2003
Inflammasomes: mechanism of action, role in disease, and therapeutics
2015 Standout
Peroxynitrite: biochemistry, pathophysiology and development of therapeutics
2007 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
2004 Standout
Complement recruitment using bispecific diabodies
1997 StandoutNobel
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
2005 Standout
Multiple sclerosis
2002 Standout
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
2006 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
1998 Standout
Nitric oxide-induced mitochondrial dysfunction: implications for neurodegeneration
2003
Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis
1999
Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis.
1996
Revised diagnostic criteria for neuromyelitis optica
2006 Standout
The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis.
1995
Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?
2007
Alzheimer's disease
1998 Standout
Nuclear magnetic resonance monitoring of treatment and prediction of outcome in multiple sclerosis
1999
Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2
2005 Standout
Multiple Sclerosis
2018 Standout
Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
2019 Standout
IMMUNOLOGY OF MULTIPLE SCLEROSIS
2005 Standout
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Of Mice and Not Men: Differences between Mouse and Human Immunology
2004 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria.
1997
Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS
2001
Nitric oxide prevents axonal degeneration by inducing HIF-1–dependent expression of erythropoietin
2011 StandoutNobel
Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain
2011 StandoutNobel
Outcomes assessment in multiple sclerosis clinical trials: a critical analysis
1995
Disease modifying therapies in multiple sclerosis: Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED]
2002
Works of S G Moore being referenced
THE PATHOPHYSIOLOGY OF ACUTE OPTIC NEURITIS
1991
MR imaging of intracranial tuberous sclerosis
1987
Serial gadolinium‐enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration
1992
High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect.
1992